Israel - Hebrew - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

Israel - Hebrew - Ministry of Health

sanofi israel ltd - sevelamer carbonate anhydrous - טבליות מצופות פילם - sevelamer carbonate anhydrous 800 mg - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ? 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Israel - Hebrew - Ministry of Health

sanofi israel ltd - sevelamer carbonate anhydrous - אבקה להכנת תרחיף - sevelamer carbonate anhydrous 2.4 g/sachet - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney diseasenot on dialysis with serum phosphorus ? 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Israel - Hebrew - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

Israel - Hebrew - Ministry of Health

voyant health ltd. - צוות טכני - disposable reflective marker spheres are intended to detect instrument coordinates and patient position with diagnostic imaging during treatment

Israel - Hebrew - Ministry of Health

"טבע מדיקל (שיווק) בע""מ" - אחות - homechoice and homechoice pro automated pd systems are intended for automatic control of dialysate solution exchanges in the treatment of pediatric and adult renal failure patients undergoing peritoneal dialysis.

Israel - Hebrew - Ministry of Health

סיגמא בי.די - רופא - מיועד לחולים מעל גיל 18 הסובלים מאי ספיקת לב סימפטומטית עקב תפקוד סיסטולי ירוד של חדר שמאל, למרות טיפול תרופתי מתאים. the optimizer iii system indicated for use in patients greater than 18 years of age with symptomatic heart failure due to left ventricular systolic dysfunction despite appropriate medical therapy

Israel - Hebrew - Ministry of Health

ג'י אי מדיקל סיסטמס ישראל - צוות טכני - system is to perform nuclear imaging procedures for detection and imaging of radioisotope tracer uptake in the patient body for clinical diagnostic purposes. discovery nm 530c is primarily intended for cardiac applications.

Israel - Hebrew - Ministry of Health

ג'י אי מדיקל סיסטמס ישראל - צוות טכני - the discovery nm/ct 570c system intended uses include performing nuclear cardiac imaging procedures for detection and imaging of radioisotope tracer uptake in the patient body for clinical diagnostic purposes as well as performing general head & body computed tomography (ct) applications

Israel - Hebrew - Ministry of Health

discover medical devices ltd. - כלל האוכלוסיה - somnuseal device is intended for multiuse purposes to provide positive air pressure (pap) treatment to a single patient or multiple patients, as a pap interface in hospitals/clinics and/or home use provided that the user was diagnosed by a physician to require pap treatment.